Solid Foundations Support Services, Plc | |
177 Murphy Rd Braintree VT 05060-8886 | |
(802) 236-4882 | |
Not Available |
Full Name | Solid Foundations Support Services, Plc |
---|---|
Speciality | Social Worker |
Location | 177 Murphy Rd, Braintree, Vermont |
Authorized Official Name and Position | Tara Tucker (LICENSED MASTER'S SOCIAL WORKER) |
Authorized Official Contact | 8022364882 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Solid Foundations Support Services, Plc 177 Murphy Rd Braintree VT 05060-8886 Ph: (802) 236-4882 | Solid Foundations Support Services, Plc 177 Murphy Rd Braintree VT 05060-8886 Ph: (802) 236-4882 |
NPI Number | 1760148944 |
---|---|
Provider Enumeration Date | 11/12/2021 |
Last Update Date | 11/12/2021 |
Certification Date | 11/12/2021 |
Identifier | Type | State | Issuer |
---|---|---|---|
1760148944 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
104100000X | Social Worker | (* (Not Available)) | Primary |
News Archive
The WHO announced Thursday it had approved a second cervical cancer vaccine, opening "U.N. agencies and partners [to] now officially buy millions of doses of the vaccine for poor countries worldwide," where an estimated 80 percent of the 280,000 annual deaths from cervical cancer occur each year, the AP/Google.com reports (7/9).
RadioIowa reports that Iowa Sen. Chuck Grassley says hospital officials around the country are seeing bugs in new health information technology software that are putting patients at risk. "'Over the last few months, concerns have been brought to my attention including administrative complications, formatting and usability issues, errors in interoperability,' Grassley says. 'Some health care providers have said the software is producing incorrect medication dosages because it miscalculated body weights by interchanging kilograms and pounds.'" Grassley is asking 32 hospitals for statements on the problem (Kelley, 1/19).
Sigma-Aldrich Corporation, a leading Life Science and High Technology company, announced it has completed its acquisition of BioReliance Holdings, Inc., a leading provider of global biopharmaceutical testing services, from Avista Capital Partners for $350 million in cash, subject to normal post-closing adjustments.
Childhood adversity is a significant problem in the US, particularly for children growing up in poverty.
› Verified 8 days ago